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Abstract
Background
Over the last decade academic interest in the prevalence and nature of herbal medicines
use by pregnant women has increased significantly. Such data are usually collected by
means of an administered questionnaire survey, however a key methodological limitation
using this approach is the need to clearly define the scope of ‘herbals’ to be investigated.
The majority of published studies in this area neither define ‘herbals’ nor provide a detailed
checklist naming specific ‘herbals’ and CAMmodalities, which limits inter-study compari-
son, generalisability and the potential for meta-analyses. The aim of this study was to com-
pare the self-reported use of herbs, herbal medicines and herbal products using two
different approaches implemented in succession.
Methods
Cross-sectional questionnaire surveys of women attending for their mid-trimester scan or
attending the postnatal unit following live birth at the Royal Aberdeen Maternity Hospital,
North-East Scotland. The questionnaire utilised two approaches to collect data on ‘herbals’
use, a single closed yes/no answer to the question “have you used herbs, herbal medicines
and herbal products in the last three months”; and a request to tick which of a list of 40 ‘herb-
als’ they had used in the same time period.
Results
A total of 889 responses were obtained of which 4.3% (38) answered ‘yes’ to herbal use via
the closed question. However, using the checklist 39% (350) of respondents reported the
use of one or more specific ‘herbals’ (p<0.0001). The 312 respondents who reported ‘no’ to
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‘herbals’ use via the closed question but “yes” via the checklist consumed a total of 20 differ-
ent ‘herbals’ (median 1, interquartile range 1–2, range 1–6).
Conclusions
This study demonstrates that the use of a single closed question asking about the use of
‘herbals’, as frequently reported in published studies, may not yield valid data resulting in a
gross underestimation of actual use.
Introduction
The increasing use of herbs, herbal medicines and herbal products (‘herbals’) to maintain health
and treat a variety of medical conditions has generated significant academic interest. Since 2005
there has been a 20 fold increase in the number of systematic reviews and a two fold increase in
prevalence surveys relating to ‘herbals’ published in peer reviewed journals (See Fig 1).
Given the paucity of robust data regarding the safety, efficacy and potential for interaction
with prescribed medication, the widespread use of ‘herbals’ by the public should be of inter-
est to the medical profession and regulatory authorities [1–4]. Of particular concern may be
use by pregnant women, who may endanger both their own health and that of their baby via
Fig 1. Number of hits over the last 10 years for Medline title search for ‘systematic review’ and ‘herb*’ and number of hits over the last 10 years for
Medline abstract search of (‘questionnaire*’ or ‘survey*’) and ‘herb*’.
doi:10.1371/journal.pone.0150140.g001
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potential herbs-drug interactions or direct toxicity from active herbal ingredients or toxic
adulterants [5–16].
A key limitation of most published studies reporting the use of ‘herbals’ is the failure to
clearly define the scope of ‘herbals’ investigated. A recent systematic review of prevalence stud-
ies reporting the use of ‘herbals’ and other complementary and alternative medicine (CAM)
modalities by pregnant women, identified that appropriate definitions of ‘herbals’ and CAMs
were only provided in twelve of twenty-two studies [17]. Furthermore, detailed checklists nam-
ing specific ‘herbals’ and CAMmodalities were described in only ten studies, with little unifor-
mity in content across studies [17]. These failings limit direct inter-study comparison,
generalisability, data pooling and the potential for meta-analyses.
This situation is not helped by the complex and major differences in the terms and defini-
tions of ‘herbals’ originating from different regulatory authorities [18–20] (Table 1). In addi-
tion there are differences between countries in the regulatory classification of ‘herbals’. For
instance in the United Kingdom some herbal products are classified as food supplements or
Table 1. Definitions of herbs, herbal medicines, herbal products and Dietary Supplements used by theWorld Health Organisation, Medicines and
Healthcare products Regulatory Agency (MHRA, United Kingdom) and the Food and Drug Administration (FDA, United States of America).
Term Deﬁnition Source
Herbal Medicine Herbal medicines include herbs, herbal materials, herbal preparations and
ﬁnished herbal products that contain as active ingredients parts of plants,
or other plant materials, or combinations
World Health Organisation (WHO), 2000 (18)
Herbs Herbs include crude plant material such as leaves, ﬂowers, fruit, seed,
stems, wood, bark, roots, rhizomes or other plant parts, which may be
entire, fragmented or powdered
WHO, 2000 (18)
Herbal materials Herbal materials include, in addition to herbs, fresh juices, gums, ﬁxed
oils, essential oils, resins and dry powders of herbs. In some countries,
these materials may be processed by various local procedures, such as
steaming, roasting, or stir-baking with honey, alcoholic beverages or other
materials
WHO, 2000 (18)
Herbal
preparations
The basis for ﬁnished herbal products and may include comminuted or
powdered herbal materials, or extracts, tinctures and fatty oils of herbal
materials. They are produced by extraction, fractionation, puriﬁcation,
concentration, or other physical or biological processes. They also include
preparations made by steeping or heating herbal materials in alcoholic
beverages and/or honey, or in other materials
WHO 2000 (18)
Finished herbal
products
Herbal preparations made from one or more herbs. If more than one herb
is used, the term mixture herbal product can also be used. Finished herbal
products and mixture herbal products may contain excipients in addition to
the active ingredients. However, ﬁnished products or mixture products to
which chemically deﬁned active substances have been added, including
synthetic compounds and/or isolated constituents from herbal materials,
are not considered to be herbal
WHO, 2000 (18)
Herbal medicine A product is a herbal medicine if the active ingredients are herbal
substances and or herbal preparations only
Medicines and Healthcare products Regulatory
Agency (MHRA), Human Medicines Regulation, UK,
2012 (19)
Herbal
preparation
A herbal preparation is when herbal substances are put through speciﬁc
processes, which include: extraction, distillation, expression, fractionation,
puriﬁcation, concentration, fermentation.
MHRA, Human Medicines Regulation, UK, 2012 (19)
Herbal substance The herbal substance being processed can be: reduced or powdered, a
tincture, an extract, an essential oil, an expressed juice, a processed
exudate (rich protein oozed out of its source).
MHRA, Human Medicines Regulation, UK, 2012 (19)
Dietary
supplement
A product that: is intended to supplement the diet. Contains one or more
dietary ingredients (including vitamins, minerals, herbs or other botanicals,
amino acids, and certain other substances) or their constituents; is
intended to be taken by mouth, in forms such as tablet, capsule, powder,
softgel, gelcap, or liquid; and is labelled as being a dietary supplement.
Dietary Supplement Health and Education Act, USA
(20)
doi:10.1371/journal.pone.0150140.t001
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cosmetics and others as medicines, while in the USA all herbal medicines and products are
described as ‘Dietary Supplements’ [21–23].
As the majority of studies assessing the use of ‘herbals’ use a questionnaire based approach,
it is essential that research participants clearly understand and correctly interpret the questions
asked. Therefore terms used in the questionnaire should be explicitly defined to ensure the col-
lection of valid data.
In an attempt to standardise data collection and reporting in CAM related studies, Quandt
et al described the development of a CAM questionnaire (I-CAM-Q) to assess self-reported
CAM use [24, 25]. The I-CAM-Q has four sections covering: visits to health care providers;
complementary treatments received from physicians; use of herbal medicine and dietary sup-
plements; and self-help practices. However, there is little specific reference to ‘herbals’ other
than: ‘have you visited a herbalist in the last 12 months?’; ‘have you received herbs from a phy-
sician in the last 12 months?’ and ‘list up to three herbs/herbal medicines you have used in the
last 12 months’. Of note there is inconsistency in the use of the terms ‘herbs’ and ‘herbal medi-
cines’, there is no definition of these terms and there is no list provided of specific ‘herbals’
from which respondents may select. These are major issues which may impact the internal
validity of the data.
Therefore the aim of our research was to assess the potential for differences in self-reported
use of ‘herbals’ using two different questioning approaches; single closed question and a list of
specific ‘herbals’ administered consecutively.
Methods
Data assessing the use of CAM collected from women (332) attending for their mid-trimester
(18–21 weeks) scan and women with a live birth admitted to the postnatal unit (557) at the
Royal Aberdeen Maternity Hospital, North-East Scotland were combined. Data collection was
completed in 2012 and study methods have been reported in detail elsewhere [26, 27]; brief
study details are given for completeness.
Questionnaires were based on the findings of our systematic review assessing the quality of
study methodologies used to derive data reporting CAM use during pregnancy ([17], S1 Ques-
tionnaire]. The questionnaire was written in English only and tested for face and content valid-
ity by a panel of researchers, healthcare professionals, pregnant and postpartum women prior
to piloting. Amongst other items, the questionnaire utilised two different approaches to collect
data on ‘herbals’ used.
The first of these was one closed question, which asked the participant to tick all of a possi-
ble 23 different Complementary and Alternative Therapies which they had used (S1 Table of
Complementary and Alternative Therapies). In the antenatal and postnatal studies participants
were asked to: “Please tell us if you have used any of the following Complementary and Alter-
native Therapies during the last three months?” The question was followed by the request to
“Please tick all Complementary and Alternative Therapies that you have used. If you haven’t
heard of some of the names before, don’t worry. For each of the Complementary and Alterna-
tive Therapies you have used, please tell us why you used it and how you heard about it (doctor,
pharmacists, midwife, family friend, internet, magazine)”. At a later stage in the questionnaire,
participants were presented with an extensive list (sourced from the Medicines and Healthcare
products Regulatory Agency (MHRA, UK)) of 40 ‘herbals’ [28] (S2 Table of Herbal and Natu-
ral Products) and asked in the antenatal and postnatal studies to “Please tell us if you have used
any of the following Herbal and Natural Products during the last three months?; The question
was then followed by the request to “Please tick all Herbal and Natural Products that you have
used. If you haven’t heard of some of the names before, don’t worry. For each of the Herbal
Two Survey Approaches to Gathering Data on Herbals Use
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and Natural Products you have used, please tell us why you used it and how you heard about it
(doctor, pharmacists, midwife, family friend, internet, magazine).
Data were analysed using descriptive statistics and a two tailed Pearson’s Chi square test to
determine associations between the two different question approaches and the proportion
answering yes to ‘herbals’ use. A P value<0.05 was considered statistically significant.
Ethics Statement
This research was approved by National Health Service North of Scotland Research Ethics
Committee and National Health Service Grampian Research and Development Committee on
June 27, 2011 (REC 11/ AL/0094). As the Ethics Committee required the survey questionnaires
to be fully anonymous and returned directly by respondents in post-paid envelopes with no
record of identifiable data, oral rather than written consent to participate was deemed
appropriate.
Results
Eight hundred and eighty-nine respondents completed the questionnaire giving an overall
response rate was 71%. Respondent demographics are reported in Table 2. Of 889 respondents,
only 4.3% (38) reported use of ‘herbals’ via the closed question. However, using the detailed list
39% (350) of respondents reported the use of one or more specific ‘herbals’. Therefore 312
(35%) respondents who reported ‘no’ to ‘herbals’ use via the closed question actually reported
“yes” to the use of herbs, herbal medicines or herbal products via the detailed list. This differ-
ence is statistically significant, p<0.0001.
Table 2. Study population demographics (n = 889).
Age (years) Percentage% (n)
15–24 15 (132)
25–34 63 (564)
35 22 (193)
Living circumstances
With spouse, partner 85 (759)
Other 15 (130)
Education
University 51 (448)
College 29 (253)
Secondary school 21 (186)
Ethnic origin
White British 80 (708)
Other 20 (173)
First pregnancy 53 (471)
Mothers’ Existing Medical conditions 26.0 (231)
Asthma 11 (95)
Hypertension 4.3 (38)
Depression 2.6 (23)
Diabetes 2.8 (25)
Epilepsy 0.7 (6)
Others 8.9 (79)
Concurrent prescribed medication 46 (406)
doi:10.1371/journal.pone.0150140.t002
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The 312 respondents who initially reported “no” actually consumed or used a total of 20 dif-
ferent ‘herbals’ (median 1, interquartile range 1–2, range 1–6) (See Fig 2).
The most frequently reported ‘herbals’ used were: raspberry tea or capsules 61% (126); gin-
ger 29% (89); cranberry 22% (70); chamomile 16% (49); peppermint 12% (36); eucalyptus 8.3%
(26); aloe 6.7% (21); grapefruit 6.4% (20); senna 5.4% (17); echinacea 4.5% (14); garlic beyond
cooking 3.5% (11); ginseng 1.3% (4); 0.6% (2) each for aconite, nettle root, dong quai; 0.3% (1)
each for barberry, bee pollen, blue cohosh, ginkgo biloba, and kava.
Binary logistic regression did not identify and significant differences, in terms of demo-
graphics, between the two study patient cohorts.
Discussion
Our key finding is that using the closed question approach, as recommended in the I-CAM-Q
[24, 25], grossly underestimated the true use of ‘herbals’ by the public. However employing a
detailed list of ‘herbals’ generated a significant tenfold increase in the number of individuals
reporting actual use.
To our knowledge this is the first study to compare two different approaches administered
consecutively to the same cohort to determine the self-reported use of ‘herbals’.
In light of these findings there are key implications for the interpretation and generalizabil-
ity for much of the research published in this area. It should not be surprising that data
reported for the use of CAMmodalities and ‘herbals’ during pregnancy are highly variable
Fig 2. Bar chart of the actual number of different herbs, herbal medicines and herbal products taken or used by those responding ‘no’ to the
closed question “have you used herbs, herbal medicines or herbal products in the last three months” (n = 312).
doi:10.1371/journal.pone.0150140.g002
Two Survey Approaches to Gathering Data on Herbals Use
PLOS ONE | DOI:10.1371/journal.pone.0150140 February 25, 2016 6 / 9
given that less than half of published prevalence studies described detailed checklists [17]. Of
note, the I-CAM-Q asks respondents to name up to three herbs/herbal medicines taken or
used in the past 12 months, therefore assuming that respondents can interpret the terms herbs
and herbal medicines, and are able to categorise accordingly. Our data provide robust evidence
that such an approach is likely to yield a gross and highly significant underestimate of true
prevalence, threatening the internal validity of the data.
Population surveys such as the I-CAM-Q are routinely used to gain a picture of public prac-
tice or belief; however it is clear from the results of this study that two simple questions, which
might at first glance be expected to give similar results, gave rise to significantly different
responses. Although writing survey questions may initially appear simple the current literature
would suggest otherwise [29–31]. The question setter must not only have a clear idea of the
question intent and the likely responses, but also ensure that questions are written using lan-
guage which the respondent can understand and process as intended [29–31]. Failure to follow
the basic principles for questionnaire design and item writing described in the literature will
inevitably give rise to misleading or erroneous survey results.
To ensure accurate and robust reporting of ‘herbals’ use during pregnancy the use of a
detailed list is clearly necessary, however this may be problematic given that the number of
available ‘herbals’ is increasing [32]. The development and application of specific checklists
will require regular review and updating to acknowledge regional and temporal variability [32,
33] in ‘herbals’ use.
Although many ‘herbals’ have been used for centuries, underestimating the level of use dur-
ing pregnancy is of clinical importance given that several of these agents have been directly
associated with or have the potential to cause both maternal and fetal harm [5–16, 34–39].
Strengths and Limitations
A key strength of this study is the consecutive administration of two different approaches to
identify ‘herbals’ use in the same population.
A possible limitation however is the use of a study population in the North of Scotland,
which may limit the generalizability of the findings. However our study population was rela-
tively diverse in terms of ethnicity, parity and health status hence there is no reason to suspect
that the outcome would be different in other populations. It is also possible that poor health lit-
eracy may have contributed to the significant differences we observed, however both
approaches were administered concurrently to the study cohort and our population was rela-
tively well educated, with over three quarters reporting a college or university education.
Therefore it is unlikely that poor health literacy was responsible for the differences we observed
between the approaches used.
Conclusion
This study has demonstrated the need to ensure that detailed checklists of ‘herbals’ are used in
all prevalence studies.
Our findings may also have relevance for the practicing clinician who should adopt detailed
checklists when asking about a patient’s use of ‘herbals’.
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